| abstract |
(57) [Summary] [Object] To provide conkanamycins D, E and G expected as active ingredients of a novel anti-atherosclerosis therapeutic agent. [Constitution] A conkanamycin-producing bacterium belonging to the genus Streptomyces is cultivated, conkanamycins D, E and G are accumulated in the culture broth, and then conkanamycins D, E and G are collected and purified from the culture broth. |